Frédéric Joliot-Curie

PMB and CEA Announce the Commissioning of iMiGiNE at Frederic Joliot Hospital (Orsay), Paving the Way for Next Generation Molecular Imaging Diagnostics

Retrieved on: 
Wednesday, May 12, 2021

b'PEYNIER, France, May 12, 2021 /PRNewswire/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020.

Key Points: 
  • b'PEYNIER, France, May 12, 2021 /PRNewswire/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020.
  • Among others, an automated system that produces in-house PET radiopharmaceuticals and linear accelerators for non-destructive testing (high-energy radiography), and radiotherapy.
  • In 2019, nearly 3,800 scientific papers were published by CEA researchers, three-quarters of which were the result of international collaboration.
  • The CEA draws on all this knowledge to carry out its other activities.\nFor more information about PMB and CEA, please visit www.pmb-alcen.com / www.cea.fr\nAdditional information about iMiGiNE can be found at www.imigine.com or follow PMB-Alcen on LinkedIn.\n'

PMB and CEA Announce the Commissioning of iMiGiNE at Frederic Joliot Hospital (Orsay), Paving the Way for Next Generation Molecular Imaging Diagnostics

Retrieved on: 
Wednesday, May 12, 2021

b'PEYNIER, France, May 12, 2021 /PRNewswire/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020.

Key Points: 
  • b'PEYNIER, France, May 12, 2021 /PRNewswire/ -- An automated radiopharmaceutical production system iMiGiNE has been installed in Frederic Joliot Hospital (CEA) in Orsay, France and commissioned in December 2020.
  • Among others, an automated system that produces in-house PET radiopharmaceuticals and linear accelerators for non-destructive testing (high-energy radiography), and radiotherapy.
  • In 2019, nearly 3,800 scientific papers were published by CEA researchers, three-quarters of which were the result of international collaboration.
  • The CEA draws on all this knowledge to carry out its other activities.\nFor more information about PMB and CEA, please visit www.pmb-alcen.com / www.cea.fr\nAdditional information about iMiGiNE can be found at www.imigine.com or follow PMB-Alcen on LinkedIn.\n'